Authors:
Polonis, VR
De Souza, MS
Chanbancherd, P
Chantakulkij, S
Jugsudee, A
Loomis-Price, LD
Vancott, TC
Garner, R
Markowitz, LE
Brown, AE
Birx, DL
Citation: Vr. Polonis et al., HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies, AIDS RES H, 17(1), 2001, pp. 69-79
Citation: Ml. Landry et al., Use of plastic vacutainer tubes for quantification of human immunodeficiency virus type 1 in blood specimens, J CLIN MICR, 39(1), 2001, pp. 354-356
Authors:
Babiker, A
Darby, S
De Angelis, D
Kwart, D
Porter, K
Beral, V
Darbyshire, J
Day, N
Gill, N
Coutinho, R
Prins, M
van Benthem, B
Coutinho, R
Dabis, F
Marimoutou, C
Ruiz, I
Tusell, J
Altisent, C
Evatt, B
Jaffe, H
Kirk, O
Pedersen, C
Rosenberg, P
Goedert, J
Biggar, R
Melbye, M
Brettie, R
Downs, A
Hamouda, O
Touloumi, G
Karafoulidou, A
Katsarou, O
Donfield, S
Gomperts, E
Hilgartner, M
Hoots, K
Schoenbaum, E
Beral, V
Zangerle, R
Del Amo, J
Pezzotti, P
Rezza, G
Hutchinson, S
Day, N
De Angelis, D
Gore, S
Kingsley, L
Schrager, L
Rosenberg, P
Goedert, J
Melnick, S
Koblin, B
Eskild, A
Bruun, J
Sannes, M
Evans, B
Lepri, AC
Sabin, C
Buchbinder, S
Vittinghoff, E
Moss, A
Osmond, D
Winkelstein, W
Goldberg, D
Boufassa, F
Meyer, L
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Tindall, B
Sharkey, T
Vizzard, J
Kaldor, J
Cunningham, P
Vanhems, P
Vizzard, J
Kaldor, J
Learmont, J
Farewell, V
Berglund, O
Mosley, J
Operskalski, E
van den Berg, M
Metzger, D
Tobin, D
Woody, G
Rusnak, J
Hendrix, C
Garner, R
Hawkes, C
Renzullo, P
Garland, F
Darby, S
Ewart, D
Giangrande, P
Lee, C
Phillips, A
Spooner, R
Wilde, J
Winter, M
Babiker, A
Darbyshire, J
Evans, B
Gill, N
Johnson, A
Phillips, A
Porter, K
Lorenzo, JI
Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Authors:
Birx, DL
Loomis-Price, LD
Aronson, N
Brundage, J
Davis, C
Deyton, L
Garner, R
Gordin, F
Henry, D
Holloway, W
Kerkering, T
Luskin-Hawk, R
McNeil, J
Michael, N
Pierce, PF
Poretz, D
Ratto-Kim, S
Renzullo, P
Ruiz, N
Sitz, K
Smith, G
Tacket, C
Thompson, M
Tramont, E
Yangco, B
Yarrish, R
Redfield, RR
Citation: Dl. Birx et al., Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers, J INFEC DIS, 181(3), 2000, pp. 881-889
Authors:
Herrmann, L
Schwan, D
Garner, R
Mobley, HLT
Haas, R
Schafer, KP
Melchers, K
Citation: L. Herrmann et al., Helicobacter pylori cadA encodes an essential Cd(II)-Zn(II)-Co(II) resistance factor influencing urease activity, MOL MICROB, 33(3), 1999, pp. 524-536